Reidling Jack C, Said Hamid M
Department of Medical Research, VA Medical Center-151, Long Beach, CA 90822, USA.
Am J Physiol Gastrointest Liver Physiol. 2005 Jun;288(6):G1127-34. doi: 10.1152/ajpgi.00539.2004. Epub 2005 Feb 10.
Thiamin participates in metabolic pathways contributing to normal cellular functions, growth, and development. The molecular mechanism of the human intestinal thiamin absorption process involves the thiamin transporters-1 (hTHTR-1) and -2 (hTHTR-2), products of the SLC19A2 and SLC19A3 genes. Little is known about adaptive regulation of the intestinal thiamin uptake process or the molecular mechanism(s) involved during thiamin deficiency. In these studies, we addressed these issues using wild-type mice and transgenic animals carrying the promoters of the hTHTR-1 and -2. We show that, in thiamin deficiency, a significant and specific upregulation in intestinal carrier-mediated thiamin uptake occurs and that this increase is associated with an induction in protein and mRNA levels of mTHTR-2 but not mTHTR-1; in addition, an increase in the activity of the SLC19A3, but not the SLC19A2, promoter was observed in the intestine of transgenic mice. Similar findings were detected in the kidney; however, expression of both thiamin transporters and activity of both human promoters were upregulated in this organ in thiamin deficiency. We also examined the effect of thiamin deficiency on the level of expression of mTHTR-1 and mTHTR-2 messages and activity of the human promoters in the heart and brain of transgenic mice and found an increase in mTHTR-1 mRNA and a rise in activity of the SLC19A2 promoter in thiamin-deficient mice. These results show that the intestinal and renal thiamin uptake processes are adaptively upregulated during dietary thiamin deficiency, that expression of mTHTR-1 and mTHTR-2 is regulated in a tissue-specific manner, and that this upregulation is mediated via transcriptional regulatory mechanism(s).
硫胺素参与有助于正常细胞功能、生长和发育的代谢途径。人体肠道硫胺素吸收过程的分子机制涉及硫胺素转运蛋白-1(hTHTR-1)和-2(hTHTR-2),它们是SLC19A2和SLC19A3基因的产物。关于肠道硫胺素摄取过程的适应性调节或硫胺素缺乏时所涉及的分子机制知之甚少。在这些研究中,我们使用野生型小鼠和携带hTHTR-1和-2启动子的转基因动物来解决这些问题。我们发现,在硫胺素缺乏时,肠道载体介导的硫胺素摄取显著且特异性地上调,这种增加与mTHTR-2而非mTHTR-1的蛋白质和mRNA水平的诱导有关;此外,在转基因小鼠的肠道中观察到SLC19A3而非SLC19A2启动子的活性增加。在肾脏中也检测到了类似的结果;然而,在硫胺素缺乏时,该器官中两种硫胺素转运蛋白的表达和两种人类启动子的活性均上调。我们还研究了硫胺素缺乏对转基因小鼠心脏和大脑中mTHTR-1和mTHTR-2信使表达水平以及人类启动子活性的影响,发现硫胺素缺乏小鼠中mTHTR-1 mRNA增加且SLC19A2启动子活性升高。这些结果表明,在饮食硫胺素缺乏期间,肠道和肾脏的硫胺素摄取过程会适应性地上调,mTHTR-1和mTHTR-2的表达以组织特异性方式受到调节,并且这种上调是通过转录调节机制介导的。